Ping Fei

1.2k total citations
52 papers, 667 citations indexed

About

Ping Fei is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ping Fei has authored 52 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Ophthalmology, 20 papers in Molecular Biology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ping Fei's work include Retinal Diseases and Treatments (11 papers), Wnt/β-catenin signaling in development and cancer (10 papers) and Retinopathy of Prematurity Studies (10 papers). Ping Fei is often cited by papers focused on Retinal Diseases and Treatments (11 papers), Wnt/β-catenin signaling in development and cancer (10 papers) and Retinopathy of Prematurity Studies (10 papers). Ping Fei collaborates with scholars based in China, United States and Australia. Ping Fei's co-authors include Peiquan Zhao, Xiang Zhang, Yian Li, Qi Zhang, Jie Peng, Yu Xu, Christine M. Sorenson, Shoujian Wang, Qiujing Huang and Jia-Kai Li and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Scientific Reports.

In The Last Decade

Ping Fei

47 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Fei China 15 354 274 235 129 79 52 667
David F. Gilmour United Kingdom 9 218 0.6× 140 0.5× 149 0.6× 69 0.5× 44 0.6× 14 363
Diego Cantalapiedra Spain 19 622 1.8× 101 0.4× 366 1.6× 26 0.2× 74 0.9× 31 755
Stefaniya Boneva Germany 16 221 0.6× 279 1.0× 534 2.3× 214 1.7× 17 0.2× 44 820
Xunlun Sheng China 14 386 1.1× 121 0.4× 249 1.1× 28 0.2× 61 0.8× 48 598
Toru Noda Japan 14 363 1.0× 513 1.9× 681 2.9× 24 0.2× 44 0.6× 46 987
R.P. Kirwan Ireland 9 226 0.6× 218 0.8× 426 1.8× 35 0.3× 71 0.9× 11 556
Prasuna Paluru United States 17 334 0.9× 391 1.4× 328 1.4× 9 0.1× 40 0.5× 20 889
Thomas M. Richardson United States 14 154 0.4× 305 1.1× 489 2.1× 14 0.1× 88 1.1× 18 651
Hema L. Ramkumar United States 12 253 0.7× 189 0.7× 366 1.6× 31 0.2× 19 0.2× 27 593
Kulwant Sehmi United Kingdom 11 212 0.6× 330 1.2× 506 2.2× 24 0.2× 18 0.2× 17 672

Countries citing papers authored by Ping Fei

Since Specialization
Citations

This map shows the geographic impact of Ping Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Fei more than expected).

Fields of papers citing papers by Ping Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Fei. The network helps show where Ping Fei may publish in the future.

Co-authorship network of co-authors of Ping Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Fei. A scholar is included among the top collaborators of Ping Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Fei. Ping Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Jia, Rong Tao, Yujie Ma, et al.. (2025). Ocular manifestations of patients with extranodal NK/T-cell lymphoma. Eye. 39(18). 3243–3248.
2.
Ye, Hongfei, Zhennan Zhao, Ping Fei, et al.. (2024). Characterization of N6-methyladenosine long non-coding RNAs in sporadic congenital cataract and age-related cataract. International Journal of Ophthalmology. 17(11). 1973–1986.
3.
Yang, Junrui, Ping Fei, Yuanzhi Yuan, et al.. (2024). Development and evaluation of a large language model of ophthalmology in Chinese. British Journal of Ophthalmology. 108(10). 1390–1397. 12 indexed citations
4.
Ye, Hongfei, Jiao Lyu, Yu Xu, et al.. (2024). Clinical observation of a modified technique for intrascleral fixation of flanged three-piece foldable intraocular lenses through a Hoffman pocket. Frontiers in Medicine. 11. 1382100–1382100. 1 indexed citations
5.
Chen, Sheng, et al.. (2024). Overexpression of TRPV1 activates autophagy in human lens epithelial cells under hyperosmotic stress through Ca2+-dependent AMPK/mTOR pathway. International Journal of Ophthalmology. 17(3). 420–434. 2 indexed citations
6.
Kou, Wei, et al.. (2022). Administration Method and Potential Efficacy of Hyaluronidase for Hyaluronic Acid Filler-Related Vision Loss: A Systematic Review. Aesthetic Plastic Surgery. 48(4). 709–718. 10 indexed citations
7.
Ye, Hongfei, Shiguang Zhang, Mi Wei, Ping Fei, & Peiquan Zhao. (2022). One-Year Outcomes of Modified Technique for Scleral Fixation of a Three-Piece Intraocular Lens Without Conjunctival Opening. Frontiers in Medicine. 9. 856800–856800. 3 indexed citations
8.
Zhang, Shanshan, Xiao Li, Wenjing Liu, et al.. (2021). Whole-Exome Sequencing Identified DLG1 as a Candidate Gene for Familial Exudative Vitreoretinopathy. Genetic Testing and Molecular Biomarkers. 25(5). 309–316. 18 indexed citations
9.
Lyu, Jiao, Qi Zhang, Yu Xu, et al.. (2021). INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY. Retina. 41(9). 1976–1985. 5 indexed citations
10.
Wang, Shiyuan, Xiang Zhang, Yiqian Hu, et al.. (2020). Clinical and genetical features of probands and affected family members with familial exudative vitreoretinopathy in a large Chinese cohort. British Journal of Ophthalmology. 105(1). 83–86. 21 indexed citations
11.
Ye, Hongfei, et al.. (2020). Case Report: Posterior Uveitis after Divalent Human Papillomavirus Vaccination in an Asian Female. Optometry and Vision Science. 97(6). 390–394. 10 indexed citations
12.
Fei, Ping. (2020). Local dry vitrectomy combined with segmental scleral buckling and viscoelastic tamponade for rhegmatogenous retinal detachment with vitreous traction. International Journal of Ophthalmology. 13(11). 1713–1719. 2 indexed citations
13.
14.
Peng, Jie, Qi Zhang, Haiying Jin, Ping Fei, & Peiquan Zhao. (2017). A Modified Technique for the Transconjunctival and Sutureless External Drainage of Subretinal Fluid in Bullous Exudative Retinal Detachment Using a 24-G i.v. Catheter. Ophthalmologica. 238(4). 179–185. 7 indexed citations
15.
Fei, Ping, et al.. (2016). SURGICAL MANAGEMENT OF ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH COMPLICATIONS. Retina. 36(8). 1480–1485. 19 indexed citations
16.
Fei, Ping, Tammy L. Palenski, Shoujian Wang, et al.. (2015). Thrombospondin-2 Expression During Retinal Vascular Development and Neovascularization. Journal of Ocular Pharmacology and Therapeutics. 31(7). 429–444. 9 indexed citations
17.
Fei, Ping, Xiong Zhu, Zhilin Jiang, et al.. (2015). Identification and functional analysis of novel FZD4 mutations in Han Chinese with familial exudative vitreoretinopathy. Scientific Reports. 5(1). 16120–16120. 13 indexed citations
18.
Fei, Ping, et al.. (2013). Clinical characteristics and treatment of 22 eyes of morning glory syndrome associated with persistent hyperplastic primary vitreous. British Journal of Ophthalmology. 97(10). 1262–1267. 29 indexed citations
19.
20.
Wang, Shoujian, Sunyoung Park, Ping Fei, & Christine M. Sorenson. (2010). Bim is responsible for the inherent sensitivity of the developing retinal vasculature to hyperoxia. Developmental Biology. 349(2). 296–309. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David F. Gilmour Breakdown of academic impact, for papers by Diego Cantalapiedra Breakdown of academic impact, for papers by Stefaniya Boneva Breakdown of academic impact, for papers by Xunlun Sheng Breakdown of academic impact, for papers by Toru Noda Breakdown of academic impact, for papers by R.P. Kirwan Breakdown of academic impact, for papers by Prasuna Paluru Breakdown of academic impact, for papers by Thomas M. Richardson Breakdown of academic impact, for papers by Hema L. Ramkumar Breakdown of academic impact, for papers by Kulwant Sehmi
Rankless by CCL
2026